Extension Study of Hetrombopag Olamine in Patients With Treatment-naive Severe Aplastic Anemia
Latest Information Update: 21 Jul 2021
At a glance
- Drugs Hetrombopag (Primary)
- Indications Aplastic anaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 21 Jul 2021 New trial record